Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: HRS-8080; SHR-A1811|DRUG: HRS-8080; SHR-A2009|DRUG: SHR-A2009; SHR-1316
Sponsor: Shandong Suncadia Medicine Co., Ltd.